Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale

Conclusion
Although procedural complications and long-term neurological event rates are low regardless of the device used, the recurrent neurological event rate was significantly lower after Amplatzer than after CardioSEAL-STARflex or Helex implantation. This has important implications regarding the interpretation of trials comparing PFO closure with medical management.

Source: European Heart Journal - November 14, 2013 Category: Cardiology Authors: Hornung, M., Bertog, S. C., Franke, J., Id, D., Taaffe, M., Wunderlich, N., Vaskelyte, L., Hofmann, I., Sievert, H. Tags: Interventional cardiology Source Type: research